Plunkett Research Online: Galapagos NV

GALAPAGOS NV (GLPGF) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Galapagos NV is an integrated biopharmaceutical company that discovers, develops and commercializes medicines with novel modes of action, addressing disease areas of high unmet medical need. The company’s pipeline comprises programs ranging from discovery to Phase 3 clinical trials in inflammation,.....


GALAPAGOS NV

Ticker: GLPGF
Exchange: GREY
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 32 15342900
Fax: 32 15342901
Address: Generaal De Wittelaan L11 A3
Mechelen, 2800 Belgium

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Onno van de Stolpe CEO
Michele Manto CCO
See More
Galapagos NV is an integrated biopharmaceutical company that discovers, develops and commercializes medicines with novel modes of action, addressing disease areas of high unmet medical need. The company’s pipeline comprises programs ranging from discovery to Phase 3 clinical trials in inflammation,.....See More See More

$USD, In whole numbers 2020 2019 2018 2017 2016 2015 2014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture